Recent Finacing
Recent Raise
Apic Bio is a Cambridge-based gene therapy firm developing dual-function AAV "silence-and-replace" therapeutics (THRIVE) for rare diseases—preclinical IND-enabling programs (Alpha‑1 AAT, SOD1 ALS) and scalable AAV manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
